State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

United States116th CongressHR-2038House of Representatives
Updated: May 15, 2019

Summary

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019 This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Referred to the House Committee on the Judiciary.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

    House of Representatives

All available records shown.